Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis

Table 3 Multivariate binary regressions in acute pancreatitis patients showing association between soluble suppression of tumorigenicity 2 levels on admission and severity, necrosis, organ failure and mortality

Variables	OR (95%CI)	P value	Variables	OR (95%CI)	P value
MAP/MSAP and SAP			Necrosis
Age	1.031 (0.969-1.097)	0.330	Age	1.019 (0.990-1.049)	0.209
BMI	2.629 (1.075-6.429)	0.034	BMI	0.973 (0.695-1.362)	0.847
Gender	1.096 (1.001-1.006)	0.910	Gender	0.529 (0.234-1.198)	0.127
CRP	1.066 (1.031-1.101)	0.002	CRP	1.009 (0.995-1.023)	0.209
sST2	1.003 (1.001-1.006)	0.000	sST2	1.000 (0.999-1.001)	0.837
Any organ failure			Mortality
Age	1.017 (0.963-1.074)	0.546	Age	1.024 (0.967-1.085)	0.411
BMI	1.407 (0.788-2.511)	0.248	BMI	1.685 (0.731-3.883)	0.220
Gender	0.246 (0.050-1.202)	0.083	Gender	0.249 (0.040-1.563)	0.138
CRP	1.030 (0.991-1.071)	0.128	CRP	1.009 (0.987-1.032)	0.415
sST2	1.006 (1.003-1.009)	0.000	sST2	1.002 (1.000-1.004)	0.012

AP: Acute pancreatitis; MAP: Mild AP; MSAP: Moderately severe AP; SAP: Severe AP; BMI: Body mass index; CRP: C-reactive protein; sST2: Soluble suppression of tumorigenicity 2.